OGEN News and Press, Oragenics Inc. From 05/20/20

Are These 3 Penny Stocks Worth A Closer Look For Robinhood & WeBull Users? If there’s one thing you know from the stock market today it’s that volatility is king. What better place to see that on a daily basis than from penny stocks . These cheap stocks fly high within a mat...

Are These Penny Stocks On Your Watch List Today? Penny stocks with news are among the most sought after. Why? In most cases, day traders look for potential catalysts that could spark momentum. In light of this, favorable news, penny stocks tweeting a big update , or significant financial in...

Oragenics (NYSEMKT: OGEN ) announces that subsidiary Noachis Terra has entered into an agreement with contract research organization (CRO) Aragen Bioscience to advance its SARS-CoV-2 vaccine candidate TerraCov2. More news on: Oragenics, Inc., Healthcare stocks news, Stocks on the move, ...

Oragenics, Inc. (NYSE American: OGEN) , (the “Company” or “Oragenics”), today announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an agreement with Aragen Bioscience, a leading contract research organization focused on accelerat...

Are These On Your List Of Penny Stocks to Watch Today? Penny stocks have been some of the best performers this year. Thanks in part to the coronavirus, cheap stocks have gone on to become industry competitors. Whether it is from the testing side or the vaccine niche, biotech penny stocks hav...

Nano cap Oragenics (NYSEMKT: OGEN ) jumps  51%  premarket on average volume in response to its announcement that it has acquired Noachis Terra, Inc., the holder of a license to the TerraCoV2 vaccine candidate from NIH's NIAID, for ~$6.5M. More news on: Oragenics, Inc., Healthca...

Addition of Industry Veteran Bolsters Oragenics’ Focus on Vaccine Development Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), today announced that it has increased the size of its board of directors and appointed Ms. Kim Murp...

Oragenics, Inc. (NYSE American: OGEN) , (the “Company” or “Oragenics”), today announced its acquisition of Noachis Terra Inc., following its entry into a stock purchase agreement (the “Stock Purchase Agreement”), to develop and commercialize TerraCoV...

Nano cap Oragenics (NYSEMKT: OGEN ) slumps  50%  premarket on increased volume in reaction to unsuccessful results from a Phase 2 clinical trial evaluating AG013 for the treatment of oral mucositis (OM) in head and neck cancer patients undergoing chemoradiation treatment. Mor...

Oragenics, Inc. (NYSE American: OGEN) , a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced today that early top-line results of the company’s Phase 2 clinical trial of AG013 in oral mucositis in chemoradi...